Cite
HARVARD Citation
Farnier, M. et al. (2015). Efficacy of alirocumab in heterozygous familial hypercholesterolemia or high cv risk populations: pooled analyses of eight phase 3 trials. Atherosclerosis. 241 (1), pp. e25-e26. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Farnier, M. et al. (2015). Efficacy of alirocumab in heterozygous familial hypercholesterolemia or high cv risk populations: pooled analyses of eight phase 3 trials. Atherosclerosis. 241 (1), pp. e25-e26. [Online].